The Jupiter, Florida-based biotechnology platform company, engages in the development, and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities in the United States and Europe.
Investor deep dive
Dyadic International on course to disrupt the status quo in manufacturing biologic vaccines and drugs
Dyadic International makes strong start to 2019 with further deals and NASDAQ move
Quick facts: Dyadic International Inc
Market Cap: $168.09 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Dyadic International Inc named herein, including the promotion by the Company of Dyadic International Inc in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE